4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-140846
Chief Executive Officer acquired 13,751 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2024-12-24 | Option exercise | +13,751 | $16.21 | $222,904 | 195,291 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2024-12-24 | Option exercise · Stock Option (Right to Buy) | −13,751 | 0 | D | ||
Loading xslF345X05/ownership.xml…